IKZF1 Deletions Are Markers of Treatment Resistance in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated within the Ongoing Risk-Adapted Pethema LAL19 Trial
Blood(2022)
关键词
lymphoblastic leukemia,acute lymphoblastic leukemia,ikzf1 deletions,ph-negative,b-cell,risk-adapted
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要